Have a personal or library account? Click to login
Effects of underlying heart failure on outcomes of COVID-19; a systematic review and meta-analysis Cover

References

  1. 1. ZHU N., ZHANG D., WANG W., LI X., YANG B., SONG J., et al. A novel coronavirus from patients with pneumonia in China, 2019. New England journal of medicine. 2020.10.1056/NEJMoa2001017709280331978945
  2. 2. TOMASONI D., ITALIA L., ADAMO M., INCIARDI RM., LOMBARDI CM., SOLOMON SD., et al. COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease. European journal of heart failure. 2020;22(6):957–66.10.1002/ejhf.1871727309332412156
  3. 3. ZHENG Y-Y., MA Y-T., ZHANG J-Y., XIE X. COVID-19 and the cardiovascular system. Nature reviews cardiology. 2020;17(5):259–60.10.1038/s41569-020-0360-5709552432139904
  4. 4. MADJID M., SAFAVI-NAEINI P., SOLOMON SD., VARDENY O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA cardiology. 2020;5(7):831–40.10.1001/jamacardio.2020.128632219363
  5. 5. CLERKIN KJ., FRIED JA., RAIKHELKAR J., SAYER G., GRIFFIN JM., MASOUMI A., et al. COVID-19 and cardiovascular disease. Circulation. 2020;141(20):1648–55.10.1161/CIRCULATIONAHA.120.04694132200663
  6. 6. LIU PP., BLET A., SMYTH D., LI H. The science underlying COVID-19: implications for the cardiovascular system. Circulation. 2020;142(1):68–78.10.1161/CIRCULATIONAHA.120.04754932293910
  7. 7. XIONG T-Y., REDWOOD S., PRENDERGAST B., CHEN M. Coronaviruses and the cardiovascular system: acute and long-term implications. European heart journal. 2020.10.1093/eurheartj/ehaa231745451332186331
  8. 8. SHI S., QIN M., SHEN B., CAI Y., LIU T., YANG F., et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA cardiology. 2020;5(7):802–10.10.1001/jamacardio.2020.0950709784132211816
  9. 9. YANGA J., ZHENG Y., GOU X., PU K., CHEN Z., GUO Q., et al. Prevalence of comorbidity and its effects in patients infected with SARS-CoV-2: a systematic review and metaanalysis. Int J Infect Dis. 2020;94:91–5.10.1016/j.ijid.2020.03.017719463832173574
  10. 10. RUMERY K., SEO A., JIANG L., CHOUDHARY G., SHAH NR., RUDOLPH JL., et al. Outcomes of coronavirus disease-2019 among veterans with pre-existing diagnosis of heart failure. ESC Heart Failure. 2021;8(3):2338–44.10.1002/ehf2.13291812038133728800
  11. 11. DEFILIPPIS EM., REZA N., DONALD E., GIVERTZ MM., LINDENFELD J., JESSUP M. Considerations for heart failure care during the COVID-19 pandemic. Heart failure. 2020;8(8):681–91.
  12. 12. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). [Internet]. Cochrane. 2022. Available from: Available from www.training.cochrane.org/handbook.
  13. 13. YONAS E., ALWI I., PRANATA R., HUANG I., LIM MA., GUTIERREZ EJ., et al. Effect of heart failure on the outcome of COVID-19—A meta analysis and systematic review. The American journal of emergency medicine. 2021;46:204–11.10.1016/j.ajem.2020.07.009734731633071085
  14. 14. LOMBARDI AF., AFSAHI AM., GUPTA A., GHOLAMREZANEZHAD A. Severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), influenza, and COVID-19, beyond the lungs: a review article. La radiologia medica. 2021;126(4):561–9.10.1007/s11547-020-01311-x768919033242204
  15. 15. ZHOU B., KOJIMA S., KAWAMOTO A., FUKUSHIMA M. COVID-19 pathogenesis, prognostic factors, and treatment strategy: Urgent recommendations. Journal of medical virology. 2021;93(5):2694–704.10.1002/jmv.2675433368358
  16. 16. GUPTA A., MADHAVAN MV., SEHGAL K., NAIR N., MAHAJAN S., SEHRAWAT TS., et al. Extrapulmonary manifestations of COVID-19. Nature medicine. 2020;26(7):1017–32.10.1038/s41591-020-0968-332651579
  17. 17. HAUDHRY F., LAVANDERO S., XIE X., SABHARWAL B., ZHENG Y-Y., CORREA A., et al. Manipulation of ACE2 expression in COVID-19. Open Heart. 2020;7(2):e001424.10.1136/openhrt-2020-001424775741333443121
  18. 18. BABAPOOR-FARROKHRAN S., RASEKHI RT., GILL D., BABAPOOR S., AMANULLAH A. Arrhythmia in COVID-19. SN Comprehensive Clinical Medicine. 2020;2(9):1430–5.10.1007/s42399-020-00454-2742619332838188
  19. 19. SALEH KB., HAFIZ A., ALSULAIMAN K., ALJUHANI O., ALHARBI S., ALHARBI A., et al. Clinical characteristics and outcomes of patients with heart failure admitted to the intensive care unit with coronavirus disease 2019 (COVID-19): a multicenter cohort study. American Heart Journal Plus: Cardiology Research and Practice. 2021;7:100033.
  20. 20. TOUSOULIS D., ANTONIADES C., BOSINAKOU E., KOTSOPOULOU M., TSIOUFIS C., TENTOLOURIS C., et al. Effects of atorvastatin on reactive hyperaemia and the thrombosis–fibrinolysis system in patients with heart failure. Heart. 2005;91(1):27–31.10.1136/hrt.2003.027110176864715604328
  21. 21. SHENOY S. Coronavirus (Covid-19) sepsis: revisiting mitochondrial dysfunction in pathogenesis, aging, inflammation, and mortality. Inflammation research. 2020;69(11):1077–85.10.1007/s00011-020-01389-z741096232767095
  22. 22. PAROHAN M., YAGHOUBI S., SERAJI A., JAVANBAKHT MH., SARRAF P., DJALALI M. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. The Aging Male. 2020;23(5):1416–24.10.1080/13685538.2020.177474832508193
  23. 23. TOMASONI D., INCIARDI RM., LOMBARDI CM., TEDINO C., AGOSTONI P., AMERI P., et al. Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study. European journal of heart failure. 2020;22(12):2238–47.10.1002/ejhf.205233179839
  24. 24. PETRILLI CM., JONES SA., YANG J., RAJAGOPALAN H., O’DONNELL L., CHERNYAK Y., et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. bmj. 2020;369.10.1136/bmj.m1966724380132444366
  25. 25. BOCCHI EA., LIMA IGCV., BISELLI B., SALEMI VMC., FERREIRA SMA., CHIZZOLA PR., et al. Worsening of heart failure by coronavirus disease 2019 is associated with high mortality. ESC Heart Failure. 2021;8(2):943–52.10.1002/ehf2.13199800666133498096
  26. 26. LLÀCER P., MANZANO L., FERNÁNDEZ C., MORENO MC., NÚÑEZ J.. Mid-term Prognostic Implication of hospitalized COVID-19 patients with Prior Heart Failure diagnosis. European Journal of Internal Medicine. 2021;88:136–8.10.1016/j.ejim.2021.02.013790651833676804
  27. 27. RUGE M., GOMEZ JMD., DE LAVALLAZ JDF., HLEPAS A., RAHMAN A., PATEL P., et al. Impact of pre-existing heart failure on 60-day outcomes in patients hospitalized with COVID-19. American heart journal plus: cardiology research and practice. 2021;4:100022.10.1016/j.ahjo.2021.100022820481234151308
  28. 28. SON M., JO YS., JO S., PARK K. Impact of COVID-19 on Heart Failure Patients in South Korea A Nationwide Population-Based Study. International Heart Journal. 2021:21–198.10.1536/ihj.21-19834544986
  29. 29. SOKOLSKI M., TRENSON S., SOKOLSKA JM., D’AMARIO D., MEYER P., POKU NK., et al. Heart failure in COVID-19: the multicentre, multinational PCHF-COVICAV registry. ESC heart failure. 2021;8(6):4955–67.10.1002/ehf2.13549865301434533287
  30. 30. MURAT B., MURAT S., MERT KU., BILGIN M., CAVUSOGLU Y. Clinical characteristics and in-hospital outcomes of COVID-19 patients with history of heart failure: a propensity score-matched study. Acta cardiologica. 2022;77(1):37–44.10.1080/00015385.2021.194576534218753
  31. 31. GOYAL P., RESHETNYAK E., KHAN S., MUSSE M., NAVI BB., KIM J., et al. Clinical characteristics and outcomes of adults with a history of heart failure hospitalized for COVID-19. Circulation: Heart Failure. 2021;14(9):e008354.10.1161/CIRCHEARTFAILURE.121.008354871164134517720
  32. 32. KUNO T., TAKAHASHI M., OBATA R., MAEDA T. Cardiovascular comorbidities, cardiac injury, and prognosis of COVID-19 in New York City. American heart journal. 2020;226:24–5.10.1016/j.ahj.2020.05.005722757332425197
  33. 33. RUMERY K., SEO A., JIANG L., CHOUDHARY G., SHAH NR., RUDOLPH JL., et al. Outcomes of coronavirus disease-2019 among veterans with pre-existing diagnosis of heart failure. ESC heart failure. 2021;8(3):2338–44.10.1002/ehf2.13291812038133728800
  34. 34. ALVAREZ-GARCIA J., LEE S., GUPTA A., CAGLIOSTRO M., JOSHI AA., RIVASLASARTE M., et al. Prognostic impact of prior heart failure in patients hospitalized with COVID-19. Journal of the American College of Cardiology. 2020;76(20):2334–48.10.1016/j.jacc.2020.09.549759876933129663
  35. 35. BELARTE-TORNERO LC., VALDIVIELSO-MORÉ S., VICENTE ELCANO M., SOLÉ-GONZÁLEZ E., RUÍZ-BUSTILLO S., CALVO-FERNÁNDEZ A., et al. Prognostic implications of chronic heart failure and utility of NT-proBNP levels in heart failure patients with SARS-CoV-2 infection. Journal of clinical medicine. 2021;10(2):323.10.3390/jcm10020323782989933477268
  36. 36. INCIARDI RM., ADAMO M., LUPI L., CANI DS., DI PASQUALE M., TOMASONI D., et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. European heart journal. 2020;41(19):1821–9.10.1093/eurheartj/ehaa388723920432383763
  37. 37. CHEN T., WU D., CHEN H., YAN W., YANG D., CHEN G., et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. bmj. 2020;368.10.1136/bmj.m1091719001132217556
  38. 38. YIN Y., ZHOU S., ZHANG X., LI Z., LIU X., JIANG C., et al. Critically ill patients with COVID-19 in China: A multicenter retrospective observational study. 2020.10.2139/ssrn.3562469
  39. 39. BAKER K., HANRATH A., SCHIM VAN DER LOEFF I., TEE S., CAPSTICK R., MARCHITELLI G. COVID-19 management in a UK NHS Foundation Trust with a High Consequence Infectious Diseases centre: a detailed descriptive analysis. 2020: 2020.05.14.20100834. doi: 10.1101/2020.05.14.20100834%J.medRxiv.
  40. 40. CARABALLO C., MCCULLOUGH M., FUERY MA., CHOUAIRI F., KEATING C., RAVINDRA NG., et al. COVID-19 infections and outcomes in a live registry of heart failure patients across an integrated health care system. PLoS One. 2020;15(9):e0238829.10.1371/journal.pone.0238829752690932997657
  41. 41. HENG G., MINGLI Z., JING D., YONG Z., WEI W., WEI Z., et al. Cardiac structural and functional characteristics in patients with coronavirus disease 2019: a serial echocardiographic study. medRxiv. 2020.10.1101/2020.05.12.20095885
  42. 42. GARIBALDI BT., FIKSEL J., MUSCHELLI J., ROBINSON M., ROUHIZADEH M., NAGY P., et al. Patient trajectories and risk factors for severe outcomes among persons hospitalized for COVID-19 in the Maryland/DC region. Medrxiv. 2020.10.1101/2020.05.24.20111864
  43. 43. LIAO X., CHEN H., WANG B., LI Z., ZHANG Z., LI W, et al. Critical care for severe COVID-19: a population-based study from a province with low case-fatality rate in China. medRxiv. 2020.
  44. 44. PARANJPE I., RUSSAK AJ., DE FREITAS JK., LALA A., MIOTTO R., VAID A., et al. Clinical characteristics of hospitalized Covid-19 patients in New York City. MedRxiv. 2020.
  45. 45. GIORGI ROSSI P., MARINO M., FORMISANO D., VENTURELLI F., VICENTINI M., GRILLI R. Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the Province of Reggio Emilia. Italy medRxiv. 2020;2020(13.20063545).10.1101/2020.04.13.20063545
  46. 46. YANOVER C., MIZRAHI B., KALKSTEIN N., MARCUS K., AKIVA P., BARER Y., et al. What factors increase the risk of complications in SARS-CoV-2–infected patients? A cohort study in a Nationwide Israeli Health Organization. JMIR public health and surveillance. 2020;6(3):e20872.10.2196/20872745110932750009
  47. 47. ARGENZIANO MG., BRUCE SL., SLATER CL., TIAO JR., BALDWIN MR., BARR RG., et al. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. bmj. 2020;369.10.1136/bmj.m1996725665132471884
  48. 48. REILEV M., KRISTENSEN KB., POTTEGÅRD A., LUND LC., HALLAS J., ERNST MT., et al. Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort. International journal of epidemiology. 2020;49(5):1468–81.10.1093/ije/dyaa140749965732887982
DOI: https://doi.org/10.2478/rjim-2022-0021 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Language: English
Page range: 6 - 27
Submitted on: Sep 8, 2022
Published on: Mar 16, 2023
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2023 Soroush Morsali, Erfan Rezazadeh-Gavgani, Mobina Oladghaffari, Shirin Bahramian, Sina Hamzehzadeh, Zahra Samadifar, Elgar Enamzadeh, Zahra Sheikhalipour, Haniyeh Moradi, Hanieh Salehi Pourmehr, Amirreza Naseri, Mohammadreza Taban-Sadeghi, Sara Daneshvar, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.